microRNAs as Promising Biomarkers of Platelet Activity in Antiplatelet Therapy Monitoring

Given the high morbidity and mortality of cardiovascular diseases (CVDs), novel biomarkers for platelet reactivity are urgently needed. Ischemic events in CVDs are causally linked to platelets, small anucleate cells important for hemostasis. The major side-effect of antiplatelet therapy are life-thr...

Descripción completa

Detalles Bibliográficos
Autores principales: Krammer, Teresa L., Mayr, Manuel, Hackl, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278969/
https://www.ncbi.nlm.nih.gov/pubmed/32423125
http://dx.doi.org/10.3390/ijms21103477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278969/
https://www.ncbi.nlm.nih.gov/pubmed/32423125
http://dx.doi.org/10.3390/ijms21103477

Ejemplares similares